Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Bauman

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 20, 2010
Utility of the carboxylesterase inhibitor bis-para-nitrophenylphosphate (BNPP) in the plasma unbound fraction determination for a hydrolytically unstable amide derivative and agonist of the TGR5 receptorH Eng, M Niosi, T S McDonald, et al.
British Journal of Clinical Pharmacology|June 9, 2007
Limited influence of UGT1A1*28 and no effect of UGT2B7*2 polymorphisms on UGT1A1 or UGT2B7 activities and protein expression in human liver microsomesVincent C Peterkin, Jonathan N Bauman, Theunis C Goosen, et al.
Bioorganic & Medicinal Chemistry Letters|January 28, 2014
Undesired versus designed enzymatic cleavage of linkers for liver targetingSrinivas R Chirapu, Jonathan N Bauman, Heather Eng, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 28, 2005
Udp-glucuronosyltransferase 2b7 is the major enzyme responsible for gemcabene glucuronidation in human liver microsomesJonathan N Bauman, Theunis C Goosen, Meera Tugnait, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 24, 2012
Optimized assays for human UDP-glucuronosyltransferase (UGT) activities: altered alamethicin concentration and utility to screen for UGT inhibitorsRobert L Walsky, Jonathan N Bauman, Karine Bourcier, et al.
Progress in Community Health Partnerships : Research, Education, and Action|July 1, 2024
Mulch Madness: A Community-Academic Partnership for Lead Poisoning PreventionKyle J Moon, Lauren N Bauman, Meghanne E Tighe, et al.
Progress in Community Health Partnerships : Research, Education, and Action|July 1, 2024
Mulch Madness: A Community-Academic Partnership for Lead Poisoning PreventionKyle J Moon, Lauren N Bauman, Meghanne E Tighe, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 30, 2015
In Vitro Kinetic Characterization of Axitinib MetabolismMichael A Zientek, Theunis C Goosen, Elaine Tseng, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 7, 2024
The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Ritlecitinib, a Janus Kinase 3 and Tyrosine-Protein Kinase Family Inhibitor, in HumansJonathan N Bauman, Angela C Doran, Gabrielle M Gualtieri, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 14, 2022
The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Abrocitinib, a Selective Janus Kinase Inhibitor, in HumansJonathan N Bauman, Angela C Doran, Amanda King-Ahmad, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 20, 2010
Utility of the carboxylesterase inhibitor bis-para-nitrophenylphosphate (BNPP) in the plasma unbound fraction determination for a hydrolytically unstable amide derivative and agonist of the TGR5 receptorH Eng, M Niosi, T S McDonald, et al.
British Journal of Clinical Pharmacology|June 9, 2007
Limited influence of UGT1A1*28 and no effect of UGT2B7*2 polymorphisms on UGT1A1 or UGT2B7 activities and protein expression in human liver microsomesVincent C Peterkin, Jonathan N Bauman, Theunis C Goosen, et al.
Bioorganic & Medicinal Chemistry Letters|January 28, 2014
Undesired versus designed enzymatic cleavage of linkers for liver targetingSrinivas R Chirapu, Jonathan N Bauman, Heather Eng, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 28, 2005
Udp-glucuronosyltransferase 2b7 is the major enzyme responsible for gemcabene glucuronidation in human liver microsomesJonathan N Bauman, Theunis C Goosen, Meera Tugnait, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 24, 2012
Optimized assays for human UDP-glucuronosyltransferase (UGT) activities: altered alamethicin concentration and utility to screen for UGT inhibitorsRobert L Walsky, Jonathan N Bauman, Karine Bourcier, et al.
Progress in Community Health Partnerships : Research, Education, and Action|July 1, 2024
Mulch Madness: A Community-Academic Partnership for Lead Poisoning PreventionKyle J Moon, Lauren N Bauman, Meghanne E Tighe, et al.
Progress in Community Health Partnerships : Research, Education, and Action|July 1, 2024
Mulch Madness: A Community-Academic Partnership for Lead Poisoning PreventionKyle J Moon, Lauren N Bauman, Meghanne E Tighe, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 30, 2015
In Vitro Kinetic Characterization of Axitinib MetabolismMichael A Zientek, Theunis C Goosen, Elaine Tseng, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 7, 2024
The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Ritlecitinib, a Janus Kinase 3 and Tyrosine-Protein Kinase Family Inhibitor, in HumansJonathan N Bauman, Angela C Doran, Gabrielle M Gualtieri, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 14, 2022
The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Abrocitinib, a Selective Janus Kinase Inhibitor, in HumansJonathan N Bauman, Angela C Doran, Amanda King-Ahmad, et al.
Pageof 6